Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012 Mar-Apr;32(2):131-6.
doi: 10.5144/0256-4947.2012.131.

Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns

Atiye Fedakar  1 , Cavit Aydogdu, Ali Fedakar, Murat Ugurlucan, Semih Bolu, Marina Iskender
Affiliations
Clinical Trial

Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns

Atiye Fedakar et al. Ann Saudi Med. 2012 Mar-Apr.

Abstract

Background and objective: Pulmonary problems are vitally important in newborns. Increased intense and mucoid secretions may lead to atelectasis, pulmonary infections, respiratory distress, prolonged mechanical ventilation or even death. The aim of this study was to evaluate the safety of recombinant human deoxyribonuclease (rhDNase) in the management of persistent atelectasis in term and preterm newborns, unresponsive to the conventional treatment.

Design and setting: Prospective study of patients admitted to a general community setting of a neonatal intensive care unit between December 2007 and December 2009.

Patients and methods: The study included 22 patients (12 premature and 10 term) who were admitted to the neonatal intensive care unit because of respiratory distress and developed atelectasis, and were unresponsive to conventional treatment. Nebulized rhDNase was administered to all patients at a dose of 1 mg/m2 twice daily for 3 days. In patients who did not respond to 3 days of treatment, endotracheal rhDNase was administered at a dose of 1 mg/m2. We assessed the clinical (respiratory rate and oxygen requirement) and radiologic responses (chest radiographic score), recurrence of atelectasis, the need for a repetitive treatment, and mortality rate.

Results: A clinical and radiologic improvement of atelectasis was observed in 18 of 22 patients following 3 days of nebulized rhDNase treatment. Atelectasis relapsed in 4 patients. Following the administration of combined endotracheal and nebulized rhDNase treatment, an improvement of atelectasis was noted in all four recurrent cases. No adverse events were observed in patients because of the rhDNase treatment.

Conclusions: rhDNase treatment is a safe option and may be used as an effective method for the management of persistent atelectasis in newborns, which is resistant to other conventional treatment methods.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest x-ray of the newborn before treatment (right partial atelectasis).
Figure 2
Figure 2
Chest x-ray of the newborn after treatment (right partial atelectasis improved with treatment).
Figure 3
Figure 3
Chest x-ray of the 28-week premature newborn before treatment (left total atelectasis was improved with treatment).
Figure 4
Figure 4
Chest x-ray of the 28-week premature newborn after treatment. (left total atelectasis was improved with treatment).
Figure 5
Figure 5
Comparison of number of breaths per minute before and after treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Guglani L, Lakshminrusimha S, Ryan RM. Transient tachypnea of the newborn. Pediatr Rev. 2008;29:e59–65. - PubMed
    1. El Hassan NO, Chess PR, Huysman MW, Merkus PJ, de Jongste JC. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics. 2001;108:468–70. - PubMed
    1. Küpeli S, Teksam O, Dogru D, Yurdakök M. Use of recombinant human DNase in a premature infant with recurrent atelectasis. Pediatr Int. 2003;45:584–6. - PubMed
    1. Durward A, Forte V, Shemie SD. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus. Crit Care Med. 2000;28:560–2. - PubMed
    1. Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJ. DNase and atelectasis in non-cystic fibrosis pediatric patients. Crit Care. 2005;9:R351–6. - PMC - PubMed

Publication types